ARCHIVES

New Treatment For Malignant Glioma, IL13-PE38, Tested In Early Clinical Trials

This article is from The Cancer Letter archive.

Vol. 24 No. 12 | December 28, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Peer Review: Consumer Advocates Named To Panels Reviewing Center Grants, ECOG Renewal

September 4, 1998

“Comprehensive” Tag For Centers A Poor Choice, Word-Conscious NCI Staff, Committee Feel

February 22, 1974

Duke Officials Decline To Provide Details Of Probe

July 23, 2010

NCCS Networker Volume 1 Issue 3, Fall 1987

September 13, 1987

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

December 31, 2010

Longer Chemo Regimen Offers Better DFS For Premenopausal Breast Cancer

January 31, 2003